The Hong Kong Stock Exchange (the Exchange) published its Consultation Conclusions on a Listing Regime for Companies from Emerging_and Innovative Sectors on 24 April 2018 (Consultation Conclusions) setting out Listing Rule changes which allow the listing on the Exchange of two new categories of company - (i) pre-revenue biotech companies and (ii) innovative and high growth issuers which have weighted voting rights (WVR).
The new Rules took effect on 30 April 2018 and also create a new secondary listing route for innovative companies with primary listings on Qualifying.